CG Oncology Corp (CGON) - Bozor kapitallashuvining balans qiymatiga nisbati
GURU.Markets platformasidagi CG Oncology, Inc. (CGON) uchun ushbu kunlik narxlar grafigi 5.48 ko'rsatkichini aks ettiradi. Biofarmatsevtika loyihasi rahbariyati IPO dan so'ng aksiyadorlarning kutganlarini samarali boshqarmoqda. Biznes klinikalarga mo'ljallangan qovuq o'smalari immunoterapiyasiga e'tibor qaratgan holda, davolashga chidamlilikka ega bo'lgan bemorlarga yordam bermoqda. Texnik infratuzilma klinik sinovlar uchun dori vositalarini ishlab chiqarish maqsadida muntazam ravishda yangilanadigan sertifikatlangan ob'ektlarni o'z ichiga oladi.
%20Kapitallashuvning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_CGON_-_CG-Oncology-Inc._-_Market-Cap-to-Net-Assets-Ratio "CG Oncology Corp (CGON) Bozor kapitallashuvining balans qiymatiga nisbati: 21.02.2024 - 30.10.2026 davri uchun | 👁️GURU.Markets👁️")
CG Oncology Inc (CGON) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Umumiy qarzning kapitalga nisbati CG Oncology, Inc.|CGON - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati CG Oncology Corp|CGON - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati CG Oncology Corp|CGON - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli majburiyatlari CG Oncology|Tezkor likvidlik koeffitsiyenti cgoncology.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:CG Oncology, Inc.
CG Oncology, Inc. (CGON) barqarorligi onkolitik virus bioinzheneriyasining noyob salohiyatiga asoslangan bo'lib, bu bozor kapitalizatsiyasining balans qiymatiga nisbati ilmiy innovatsiyalar uchun bozor premiumining ko'rsatkichi bo'lishini ta'minlaydi. Ushbu grafik joriy bozor qiymatini sof aktivlar bilan solishtiradi, bunda barqaror tendentsiya intellektual kapitalning adolatli baholanganini tasdiqlaydi, uzoq muddatli pasayish esa operatsion marjaning qisqarishi xavfidan signal beradi.
CG Oncology, Inc. kimlar bilan raqobatlashadi
BeiGene Ltd (ONC) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati HALO|RVMD (Revolution Medicines, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International (AAPG)|Bozor kapitallashuvining balans qiymatiga nisbati URGN|Bozor kapitallashuvining balans qiymatiga nisbati Bicara Corp (BCAX)|Bozor qiymatining balans qiymatiga nisbati Personalis, Inc. PSNL|ERAS: Kapitallashuvning balans qiymatiga nisbati|Delcath Systems - Bozor kapitallashuvining balans qiymatiga nisbati|Y-mAbs Therapeutics Inc (YMAB) - Kapitallashuvning sof aktivlarga nisbati|AURA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Candel Therapeutics, Inc. (CADL)|Bozor qiymatining balans qiymatiga nisbati Accuray Incorporated|SLS: Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati ACTU (Actuate Therapeutics)|CTOR (Citius Oncology Inc.) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati HURA (TuHURA Biosciences)|TARA - Kapitallashuvning sof aktivlarga nisbati|FATE: Kapitallashuvning sof aktivlarga nisbati|WHWK - Bozor kapitallashuvining balans qiymatiga nisbati|tscan.com (TCRX) - Bozor qiymatining balans qiymatiga nisbati|Champions Oncology, Inc. - Balans qiymatiga nisbatan bozor qiymati|XBIT (XBiotech Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti CEL-SCI Corp CVM|Bozor kapitallashuvining balans qiymatiga nisbati OSTX|Kapitallashuvning sof aktivlarga nisbati Radiopharm Theranostics Ltd RADX|Bozor kapitallashuvining balans qiymatiga nisbati ARTV (Artiva Biotherapeutics)|Bozor qiymatining xususiy kapitalga nisbati Adlai Nortye Ltd|VERU: Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati TPST (Tempest Therapeutics Corp)|xiliotx.com (XLO) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Renovaro (RENB)|Bozor qiymatining balans qiymatiga nisbati Mural Oncology PLC|Kapitallashuvning balans qiymatiga nisbati KAPA (Kairos Pharma Inc)|Bozor kapitallashuvining balans qiymatiga nisbati OKUR|Kapitallashuvning sof aktivlarga nisbati w2.cytomed.sg GDTC|Bozor qiymatining balans qiymatiga nisbati Curis CRIS|Apollomics Inc. (APLM) - Bozor qiymatining balans qiymatiga koeffitsiyenti|THAR - Bozor qiymatining balans qiymatiga nisbati|ADVB: Bozor qiymatining balans qiymatiga nisbati|Genprex, Inc (GNPX) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Calidi Biotherapeutics, Inc. (CLDI)|SBFM (Sunshine Biopharma) - Bozor kapitallashuvining balans qiymatiga nisbati|XBIO - Bozor qiymatining xususiy kapitalga nisbati|Kapitallashuvning sof aktivlarga nisbati SLRX (Salarius Pharmaceuticals, Inc.)|PPBT - Bozor qiymatining balans qiymatiga koeffitsiyenti|American Oncology Network, Inc. - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati BGNE|Checkpoint Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Elevation Oncology Inc. ELEV|icadmed.com (ICAD) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati IKNA|NTBL (Notable Labs Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Viracta (VIRX)|Kapitallashuvning sof aktivlarga nisbati MOR (MorphoSys AG)|Balans qiymatiga nisbatan bozor kapitallashuvi nayabiosciences.com|Bozor kapitallashuvining balans qiymatiga nisbati AAPGV (Ascentage Pharma)